These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The importance of obesity in diabetes and its treatment with sibutramine.
    Author: Van Gaal LF, Peiffer FW.
    Journal: Int J Obes Relat Metab Disord; 2001 Dec; 25 Suppl 4():S24-8. PubMed ID: 11916103.
    Abstract:
    Weight gain is a known risk factor for the development of type 2 diabetes and even modest weight reduction can reduce the risk of developing diabetes, so controlling body weight is an important public health goal in the fight against diabetes and its comorbidities. Weight reduction is also a cornerstone of diabetes management, improving glycaemic control and reducing other risk factors associated with this disease. Pharmacotherapies such as sibutramine contribute to the management of type 2 diabetes in overweight and obese patients.
    [Abstract] [Full Text] [Related] [New Search]